Big pharma poured £57million into patient charities which influence NHS drug decision makers

Bath University researchers found that donations by big pharma and other industry bodies 2014-2016 rose by a 3rd. This was accompanied by a lack of transparency over how funding is reported or how the focus of charities and policy maker beneficiaries shift into commercial benefit. We’ve seen it for years in the addiction ‘treatment’ field.